Zymeworks (ZYME) Free Cash Flow (2021 - 2026)

Zymeworks has disclosed Free Cash Flow across 6 years of filings, most recently posting -$45.8 million for Q1 2026.

• Free Cash Flow for Q1 2026 came in at -$45.8 million, down 1238.53% year-over-year; the trailing twelve-month figure through Mar 2026 was -$75.4 million (up 0.54% YoY), and the FY2025 annual result was -$33.0 million, up 70.01% from the prior year.
• Free Cash Flow came in at -$45.8 million for Q1 2026 at Zymeworks, down from -$9.3 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $320.6 million in Q4 2022 to a low of -$83.6 million in Q1 2023.
• The 5-year median for Free Cash Flow is -$31.8 million (2025), against an average of -$10.2 million.
• Across the five-year window, Free Cash Flow surged 679.9% in 2022 and sank 1238.53% in 2026, its largest moves.
• Zymeworks' Free Cash Flow stood at $320.6 million in 2022, then sank by 95.77% to $13.6 million in 2023, then tumbled by 393.39% to -$39.8 million in 2024, then surged by 76.6% to -$9.3 million in 2025, then tumbled by 391.66% to -$45.8 million in 2026.
• The last three Free Cash Flow figures came in at -$45.8 million (Q1 2026), -$9.3 million (Q4 2025), and -$31.8 million (Q3 2025), per Business Quant data.